SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 29, 2016 Date of Report (Date of Earliest Event Reported) GLOBAL REGENERATIVE TECHNOLOGIES & THERAPIES INC. (Exact Name of Registrant as Specified in its Charter) A2M REGENERATIVE TECHNOLOGIES INC. (Former Name of Registrant as Specified in its Charter) Delaware 000-55480 47-4460112 (State or other (Commission File Number) (IRS Employer jurisdiction of incorporation) Identification No.) 888 Prospect Street, Suite 200 La Jolla, California 92037 (Address of principal executive offices) (zip code) 888-263-2955 (Registrant's telephone number, including area code 215 Apolena Avenue Newport Beach, California 92662 (Former Address of Principal Executive Offices) ITEM 5.03 Amendments to Articles of Incorporation The shareholders of the Corporation and the Board of Directors unanimously approved the change of the Registrant's name to Global Regenerative Technologies & Therapies Inc. and filed such change with the State of Delaware. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized. GLOBAL REGENERATIVE TECHNOLOGIES & 				 THERAPIES INC. Date: December 5, 2016 /s/ Stefan Kasian Chief Executive Officer